Some of our cancer centers are experiencing issues.  View More Important Notifications x
texas oncology more breakthroughs. more victories

Amarillo Blood and Transplant Program Receives Prestigious Honor

Program One of Eight in Texas to be Awarded Accreditation by Foundation for the Accreditation of Cellular Therapy for both Autologous and Allogeneic Transplants

AMARILLO, Texas (May 8, 2013) — The Amarillo Blood and Marrow Transplant Program (ABMTP) – consisting of Texas Oncology–Amarillo Cancer Center, Northwest Texas Hospital, and Coffee Memorial Blood Center – today announced that it is one of only eight adult stem cell transplant services in Texas, and one of only 100 in the U.S., accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) for both adult autologous and allogeneic blood stem cell transplants.

Accreditation is awarded to only a limited number of transplant programs that demonstrate an exceptional level of patient care and medical and laboratory practices in the United States, Canada, and Australia. FACT’s extensive on-site inspection included every aspect of the blood stem cell transplant program, from patient care and laboratory practices to administrative systems.

ABMTP received FACT accreditation for its autologous transplant program in 2010. “With the new allogeneic transplant accreditation, more Amarillo area patients will have access to a total-therapy approach in their local community and receive leading-edge care comparable to that in larger programs,” said Dr. Vance Esler, a hematologist with Texas Oncology–Amarillo Cancer Center.

“FACT accreditation further establishes the program as one of the elite blood and marrow transplant centers in the world and emphasizes the exceptional quality of our program,” said Dr. Seah Lim, Texas Oncology–Amarillo Cancer Center physician and director of ABMTP. “Amarillo residents can be confident that they are receiving the highest quality of care locally, meaning that our patients will not have to leave the critical support of friends and family to seek care.”

Since 2001, a multidisciplinary team from the Blood and Marrow Transplant Program has provided blood and marrow stem cell transplantation to patients, primarily those with leukemia, lymphoma, myelodysplastic syndromes, and multiple myeloma. Transplantation replaces bone marrow stem cells that have been destroyed by high doses of chemotherapy or radiation therapy with the patient’s own non-cancerous cells (autologous) or cells from someone other than the patient (allogeneic).

ABMTP is committed to providing exceptional seamless service from diagnosis to becoming disease-free for patients with blood cancers. Such patients can now be treated right here near their homes with the assurance that they will receive the same level of care that they used to have to travel hundreds of miles to obtain.

For more information about Amarillo Blood and Marrow Transplant Program, contact Dr. Seah H. Lim at the Texas Oncology–Amarillo Cancer Center, 806-358-8654 or via email at

Related Cancer Centers